Ningbo Ketuo Electronic Technology Co., Ltd – Trademark Portfolio

Entity Type: 16

Ningbo Ketuo Electronic Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RESCTOL. The owner is based in Zhejiang Province.

2-10, No.38,Science and Technology Plaza

Ningbo High-tech Zone

Zhejiang Province 315000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RESCTOL
RESCTOL
Registered 2022

Trademark Classifications

Ningbo Ketuo Electronic Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Ningbo Ketuo Electronic Technology Co., Ltd have?

Ningbo Ketuo Electronic Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Ningbo Ketuo Electronic Technology Co., Ltd file in?

Ningbo Ketuo Electronic Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Ningbo Ketuo Electronic Technology Co., Ltd's most well-known trademarks?

Ningbo Ketuo Electronic Technology Co., Ltd's registered trademark portfolio includes well-known marks such as RESCTOL. These are among 1 currently registered trademark in the portfolio.

What is Ningbo Ketuo Electronic Technology Co., Ltd's trademark registration success rate?

Ningbo Ketuo Electronic Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.